Patent 11390917 was granted and assigned to Bio-Rad Laboratories on July, 2022 by the United States Patent and Trademark Office.
The invention generally relates to droplet based digital PCR and methods for analyzing a target nucleic acid using the same. In certain embodiments, a method for determining the nucleic acid make-up of a sample is provided.